Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| FK-739, 136042-19-8 ; 133052-30-9 (free), FK-739 Intermediate 452-58-4, stock 705.4g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply. |
| FK-739, 136042-19-8 ;133052-30-9 (free), FK-739 Intermediate 109-52-4, stock 789.5g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
| FK-739, 136042-19-8 ; 133052-30-9 (free), FK-739 Intermediate 68175-10-0, stock 620g, white powder, assay by HPLC 99.2%, HNMR, LCMS we supply. |
| FK-739, 136042-19-8 ; 133052-30-9 (free), FK-739 Intermediate 114772-54-2, stock 453.7g, white powder, assay by HPLC 98%, HNMR, LCMS we supply. |
| FK-739, 136042-19-8 ; 133052-30-9 (free), FK-739 Intermediate 133705-01-8, stock 536.4g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
| FK-739, 136042-19-8 ; 133052-30-9 (free), FK-739 Intermediate 133052-30-9, stock 708.6g, white powder, assay by HPLC 98%, HNMR, LCMS we supply. |
